ASE Technology (ASX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 net revenues reached NT$140,238 million, up 6% sequentially and 3% year-over-year, with strong demand for leading-edge products and selective recovery in traditional segments.
Net income attributable to shareholders was NT$7,783 million, up 37% sequentially and 1% year-over-year; basic EPS was NT$1.80, up 36% sequentially and flat YoY.
Investments are increasing in leading-edge packaging, testing, labor, and equipment to meet growing complexity and demand.
Financial highlights
Q2 consolidated net revenues rose 6% sequentially and 3% year-over-year; gross profit was NT$23,066 million with a 16.4% margin, up 0.7pp sequentially and 0.4pp YoY.
Net income was NT$7,783 million, up NT$2,101 million sequentially and flat YoY; EPS was NT$1.80 (basic), NT$1.75 (diluted).
Operating profit reached NT$9,021 million, up NT$1,500 million sequentially but down NT$400 million YoY; operating margin up 0.7pp sequentially, down 0.5pp YoY.
EBITDA for Q2 2024 was NT$26,127 million, up from NT$23,974 million in Q1 2024.
Excluding PPA, gross margin was 17.1%, operating margin 7.3%, net margin 6.4%, and basic EPS NT$2.08.
Outlook and guidance
Q3 ATM revenue expected to grow high single digits QoQ; gross margin guided at 23%-23.5%.
Q3 EMS revenue to grow mid-to-high single digits QoQ; operating margin to exceed Q4 2023's 3.5%.
Full-year growth now expected to be moderate due to slower general market recovery, but leading-edge remains strong.
Full-year ATM margin target remains at structural range (~24%), but Q3 may fall short due to muted recovery.
CapEx for 2024 to double from 2023, focused on leading-edge ATM capacity and technology advancement.
Latest events from ASE Technology
- Strong 2025 results and robust 2026 outlook driven by AI, advanced packaging, and margin gains.ASX
Q4 20255 Feb 2026 - Q3 2024 net income rose to NT$9,666m on strong packaging, test, and capex for future growth.ASX
Q3 202417 Jan 2026 - Advanced packaging and testing drove 2024 growth, with strong 2025 outlook and major CapEx planned.ASX
Q4 20248 Jan 2026 - Q1 2025 net income up 33% year-over-year; ATM drives growth, EMS faces softness.ASX
Q1 202520 Dec 2025 - 7–9% revenue growth in H1/Q2 2025, led by advanced packaging and testing momentum.ASX
Q2 20256 Nov 2025 - Q3 2025 net income rose to NT$10,870 million on 11.8% sequential revenue growth, led by ATM.ASX
Q3 202530 Oct 2025